03/06/2025 21:11
|
Science
Two-Part Dose Escalation and Expansion Trial Will Evaluate Efficacy and Safety of BYON4228 Alone and in Combination with Pembrolizumab
NIJMEGEN, The Netherlands--BUSINESS WIRE--
Byondis B.V.,...